Virological response and safety of 24-week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1b.
about
Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines.Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions.Renal impairment during the treatment of telaprevir with peginterferon and ribavirin in patients with chronic hepatitis C.A translational study of resistance emergence using sequential direct-acting antiviral agents for hepatitis C using ultra-deep sequencing.Full-length sequence analysis of hepatitis E virus isolates: showing potential determinants of virus genotype and identity.Dermatological side-effects of telaprevir-based triple therapy for chronic hepatitis C in phase III trials in Japan.
P2860
Virological response and safety of 24-week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1b.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Virological response and safet ...... hepatitis C virus subtype 1b.
@ast
Virological response and safet ...... hepatitis C virus subtype 1b.
@en
type
label
Virological response and safet ...... hepatitis C virus subtype 1b.
@ast
Virological response and safet ...... hepatitis C virus subtype 1b.
@en
prefLabel
Virological response and safet ...... hepatitis C virus subtype 1b.
@ast
Virological response and safet ...... hepatitis C virus subtype 1b.
@en
P2093
P2860
P1476
Virological response and safet ...... hepatitis C virus subtype 1b.
@en
P2093
S Takahashi
P2860
P304
P356
10.1111/J.1365-2893.2012.01640.X
P577
2012-07-13T00:00:00Z